Effects of salmeterol and fluticasone propionate combination versus fluticasone propionate on airway function and eosinophilic inflammation in mild asthma

Allergology International

Volumn 58, Issue 3, 2009, Pages 357-363

  Hoshino, Makoto ^a,b   Handa, Hiroshi ^a   Miyazawa, Teruomi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b International University of Health and Welfare   (Japan)

Author keywords

Asthma; Fluticasone propionate; Impulse oscillometry; Salmeterol and fluticasone propionate; Sputum eosinophils

Indexed keywords

BECLOMETASONE DIPROPIONATE; DISKUS; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG RESISTANCE; MALE; MILD PERSISTENT ASTHMA; OSCILLOMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION; SPIROMETRY; SPUTUM ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 70450193558     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.08-OA-0065     Document Type: Article

References (32)

1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. National Heart, Lung, and Blood Institute/World Health Organization, Updated 2005. Available from: http://www.ginasthma.org.
2. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994; 344:219-224
3. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-1488 (Pubitemid 26141329)
4. Matz J, Emmett A, Rickard K, Kalberg C. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations. J Allergy Clin Immunol 2001;107:783-789 (Pubitemid 32436910)
5. van Noord JA, Schreurs AJ, Mol SJ, Mulder PG. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. Thorax 1999;54:207-212 (Pubitemid 29110499)
6. Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group. Ann Allergy Asthma Immunol 1999;82:383-389 (Pubitemid 29203287)
7. Bateman ED, Boushey HA, Bousquet J et al; GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004;170:836-844 (Pubitemid 39346477)
8. Houghton CM, Woodcock AA, Singh D. A comparison of lung function methods for assessing dose-response effects of salbutamol. Br J Clin Pharmacol 2004;58:134-141 (Pubitemid 39043993)
9. Goldman MD. Clinical application of forced oscillation. Pulm Pharmacol Ther 2001;14:341-350
10. Pizzichini E, Pizzichini MM, Efthimiadis A et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308-317 (Pubitemid 26269096)
11. Pin I, Gibson PG, Kolendowicz R et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25-29
12. Nathan RA, Sorkness CA, Kosinski M et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59-65. (Pubitemid 38096162)
13. Oostveen E, MacLeod D, Lorino H et al. ERS Task Force on Respiratory Impedance Measurements. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J 2003;22:1026-1041
14. Goldman MD, Carter R, Klein R, Fritz G, Carter B, Pachucki P. Within- and between-day variability of respiratory impedance, using impulse oscillometry in adolescent asthmatics. Pediatr Pulmonol 2002;34:312-319
15. Oppenheimer BW, Goldring RM, Herberg ME et al. Distal airway function in symptomatic subjects with normal spirometry following World Trade Center dust exposure. Chest 2007;132:1275-1282
16. The Committee of Pulmonary Physiology, The Japanese Respiratory Society. [Guidelines for Pulmonary Function Tests. Spirometry, Flow Volume Curve, Diffusion Capacity of the Lung]. Tokyo: The Japanese Respiratory Society, 2004 (in Japanese).
17. Fujimura M, Songür N, Kamio Y, Matsuda T. Detection of eosinophils in hypertonic saline-induced sputum in patients with chronic nonproductive cough. J Asthma 1997; 34:119-126 (Pubitemid 27168501)
18. Currie GP, Stenback S, Lipworth BJ. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma. Br J Clin Pharmacol 2003;56:11-17 (Pubitemid 36886483)
19. Wagner EM, Liu MC, Weinmann GG, Permutt S, Bleecker ER. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis 1990;141:584-588 (Pubitemid 20109142)
20. Kraft M. The distal airways: are they important in asthma? Eur Respir J 1999;14:1403-1417 (Pubitemid 30019540)
21. Pride NB. Forced oscillation techniques for measuring mechanical properties of the respiratory system. Thorax 1992;47:317-320
22. Mead J. Contribution of compliance of airways to frequency dependent behaviour of lungs. J Apply Physiol 1969;26:670-673
23. Van Noord JA, Clément J, Van de Woestijne KP, Demedts M. Total respiratory resistance and reactance in patients with asthma, chronic bronchitis, and emphysema. Am Rev Respir Dis 1991;143:922-927
24. Bouaziz N, Beyaert C, Gauthier R, Monin P, Peslin R, Marchal F. Respiratory system reactance as an indicator of the intrathoracic airway response to methacholine in children. Pediatr Pulmonol 1996;22:7-13. (Pubitemid 26269736)
25. Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma. Respir Med 1999;93:876-884 (Pubitemid 30042638)
26. Fahy JV, Wong H, Liu J, Boushey HA. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am J Respir Crit Care Med 1995;152:53-58
27. Usmani OS, Ito K, Maneechotesuwan K et al. Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am J Respir Crit Care Med 2005;172:704-712 (Pubitemid 41324225)
28. Johnson M. Effects of beta2-agonists on resident and infiltrating inflammatory cells. J Allergy Clin Immunol 2002; 110:S282-90. (Pubitemid 35471717)
29. Li X, Ward C, Thien F et al. An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med 1999;160:1493-1499
30. Kavuru M, Melamed J, Gross G et al. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, doubleblind, placebo-controlled trial. J Allergy Clin Immunol 2000;105:1108-1116 (Pubitemid 30418788)
31. Murray J, Rosenthal R, Somerville L et al. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2- agonists. Ann Allergy Asthma Immunol 2004;93:351-359 (Pubitemid 39382976)
32. Mcivor RA, Pizzichini E, Turner MO, Hussack P, Hargreave FE, Sears MR. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med 1998;158:924-930 (Pubitemid 28449462)